Results 201 to 210 of about 15,146 (241)
Some of the next articles are maybe not open access.
Immunology of Vaccine Adjuvants
2009In recent times vaccine adjuvants, or immunopotentiators, received abundant attention in the media as critical ingredients of current and future vaccines. Indeed, vaccine adjuvants are recognized to make the difference between competing vaccines based on identical antigens.
Ribeiro, C.M.S., Schijns, V.E.J.C.
openaire +2 more sources
Cytokines as immunological adjuvants
Vaccine, 1992Various cytokines have been shown to be effective immunological adjuvants in a variety of model systems, enhancing protection induced by viral, bacterial and parasitic vaccines, and increasing parameters of immunity in tumour immunization models and in clinical trials.
A W, Heath, J H, Playfair
openaire +2 more sources
Recombinant cytokines as immunological adjuvants
Immunology & Cell Biology, 1993SummaryThis paper describes the bacterial expression and purification of bioactive recombinant ovine interleukin‐2 (rovIL‐2), interleukin‐lα (rovlL‐lα) and tumour necrosis factor α. These purified proteins had specific activities in appropriate bioassays of 1 × 107, 1 times; 107 and 1 × 105 U/mg, respectively.
Nash, AD +7 more
openaire +3 more sources
Lithium as an immunologic adjuvant
Medical Hypotheses, 1980Lithium, an adenylate cyclase inhibitor, stimulates a variety of in vitro indices of immune function, including proliferation of lymphocytes in response to mitogens, rosette formation by T-cells and phagocytosis by macrophages. Lithium enhances these immunologic responses at concentrations comparable to those achieved in patients receiving lithium for ...
L, Shenkman, W, Borkowsky, B, Shopsin
openaire +2 more sources
DDA as an immunological adjuvant
Research in Immunology, 1992As compared to other adjuvants, DDA is a moderate or strong adjuvant for humoral responses and a strong adjuvant for CMI, especially DTH responses, against different types of antigens and in both laboratory animals and larger animals. DDA can collaborate with other immunomodulating compounds resulting in further enhanced responses.
L A, Hilgers, H, Snippe
openaire +2 more sources
Glycolipids as potential immunologic adjuvants
Journal of Medicinal Chemistry, 1980A group of 1-thio-beta-L-fucopyranosides containing hexadecane, 9-octadecene, adamantane, 1,2-diphenyltetrafluoroethane, and 3-hexynyl- and 3,6-dioxaoctylcholesterols were synthesized as potential immunologic adjuvants. Many of these fucosyl lipids and 6-(5-cholesten-3 beta-yloxy)hexyl 1 thioglycosides were found to give good response to subunit A ...
M M, Ponpipom +3 more
openaire +2 more sources
Glucans as Immunological Adjuvants
1995β-1,3-Linked glucopyranose (β-glucan), a major structural component of yeast, fungi, and algae [1], has a wide range of biological activities. Systemic administration of β-glucan (1) provides nonspecific resistance in experimental animals against a variety of pathogenic challenges [2–7]; (2) prolongs the survival time of tumor-bearing animals [8,9]; (3)
N. Mohagheghpour +11 more
openaire +2 more sources
Adjuvant-free immunological manipulation of livestock
Research in Veterinary Science, 1984Mice and sheep were immunised to growth hormone release inhibiting hormone (GHRIH) using a number of systems which avoided conventional adjuvants. GHRIH was linked directly, or via a horse IgG carrier, to algin or purified protein derivative of tuberculin. A conjugate of GHRIH and flagella from Salmonella dublin was also prepared.
C A, Morrison, J, Williams, B N, Perry
openaire +2 more sources
Immunology of TLR-independent vaccine adjuvants
Current Opinion in Immunology, 2009Vaccine adjuvants target the innate immune system to enhance the immunogenicity of coadministered antigens. Dendritic cells (DCs) are responsible for antigen uptake and presentation to naïve T cells and represent a key target of adjuvant activity. Adjuvants derived from microbial components, such as Toll-like receptor (TLR) agonists, elicit innate ...
Ennio, De Gregorio +2 more
openaire +2 more sources
Co-stimulatory agonists as immunological adjuvants
Vaccine, 2006The considerable advances made in the fields of molecular biology, genomics, proteomics and protein engineering have led to the identification of a vast range of potential vaccine antigens for a host of man's most serious diseases. However, experience informs us that vaccines based on recombinant proteins and synthetic peptides lack the immunogenicity ...
Tom A, Barr +2 more
openaire +2 more sources

